Bangladesh vs Tonga: Pneumococcal conjugate second or third-dose vaccines (PCVc)
Bangladesh
94.0%
in 2025
Tonga
94.0%
in 2025
Bangladesh rank
44th
Tonga rank
44th
Pneumococcal conjugate second or third-dose vaccines (PCVc) over time
- Bangladesh
- Tonga
How they compare
Bangladesh currently reports 94.0% against 94.0% in Tonga, a difference of 0.0%.
The two have swapped places 2 times across 18 shared years of data; in 2008 it was Tonga ahead.
Bangladesh ranks 44th and Tonga ranks 44th of 192 countries.
Bangladesh has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Bangladesh | Tonga | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.0% | 0.0% | 0.0% | — |
| 2010s | 44.1% | 0.0% | 44.1% | Bangladesh |
| 2020s | 96.8% | 71.0% | 25.8% | Bangladesh |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher pneumococcal conjugate second or third-dose vaccines (pcvc), Bangladesh or Tonga?
- Bangladesh, at 94.0% against 94.0% in Tonga as of 2025.
- What is the difference in pneumococcal conjugate second or third-dose vaccines (pcvc) between Bangladesh and Tonga?
- 0.0%, with Bangladesh ahead.
- How many years of comparable data are there for Bangladesh and Tonga?
- 18 years are reported by both, from 2008 to 2025.
- How do Bangladesh and Tonga rank globally for pneumococcal conjugate second or third-dose vaccines (pcvc)?
- Bangladesh ranks 44th and Tonga ranks 44th of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Pneumococcal conjugate second or third-dose vaccines (PCVc) immunization coverage by the locally recommended age (%) (WUENIC). Statizoid refreshes it automatically from the source and publishes the full history for both places.